Internal Medicine · Dallas, TX
NPI
1891757613
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
219 Sunset Ave Ste 116a
Dallas, TX, 75208
Phone (972) 807-7370
Groups this clinician bills Medicare through
Medicare paid, 2024
$16K
234 services
Medicare patients, 2024
36
Average age 63
Drug cost, 2024
$4.6M
6,016 prescriptions
Company payments, 2025
$89K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gary I Sinclair was code 99214 (office e&m - established), 69 times for 33 patients. In total Gary I Sinclair billed 234 services in 26 codes, and Medicare paid $16K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 69 | 33 | $81.93 | $5,653 |
| 96127 Behavioral Health Services | Office | 31 | 18 | $3.95 | $122 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 17 | 17 | $138.73 | $2,358 |
| G0008 Administration of influenza virus vaccine | Office | 12 | 12 | $30.79 | $370 |
By year: 2022 $14K for 353 services; 2023 $10K for 156 services; 2024 $16K for 234 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gary I Sinclair prescribed most often to Medicare patients was Rosuvastatin Calcium, with 339 prescriptions and refills. In total Gary I Sinclair wrote 6,016 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 339 | 409 | 48 | $1,263 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 292 | 294 | 33 | $1.3M |
| Amlodipine Besylate Generic | 176 | 207 | 24 | $391 |
| Atorvastatin Calcium Generic | 175 | 236 | 27 | $855 |
| Losartan Potassium Generic | 143 | 190 | 23 | $478 |
| Famotidine Generic | 140 | 156 | 18 | $828 |
| Tivicay Dolutegravir Sodium | 136 | 136 | 18 | $328K |
| Dovato Dolutegravir Sodium/Lamivudine | 134 | 134 | 18 | $388K |
| Gabapentin Generic | 128 | 132 | 18 | $849 |
| Fluticasone Propionate Generic | 122 | 155 | 18 | $1,451 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 108 | 112 | 22 | $3,093 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 107 | 107 | 13 | $384K |
| Descovy Emtricitabine/Tenofov Alafenam | 107 | 107 | 12 | $222K |
| Valacyclovir Valacyclovir Hcl | 106 | 120 | 14 | $3,620 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 104 | 104 | 15 | $383K |
Brand drugs: 1,886 claims; generic drugs: 4,091 claims; opioid claims: 66.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gary I Sinclair $89K ($88K in general payments such as food, travel and fees and $742 for research) from 10 companies. The largest payer was ViiV Healthcare Company with $68K.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 126 | $68K |
| Merck Sharp & Dohme LLC MRK | 32 | $9,062 |
| Theratechnologies Inc. THTX | 15 | $8,876 |
| Gilead Sciences, Inc. GILD | 21 | $2,327 |
| EMD Serono, Inc. MRK.DE | 7 | $147 |
| Novo Nordisk Inc NVO | 6 | $116 |
| Pfizer Inc. PFE | 2 | $50.6 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $28.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.